New Approach to VNS Therapy

AspireSR VNS
Wednesday, June 17, 2015

The Food and Drug Adminstration (FDA) has approved a new generator for the VNS Therapy® System. The new generator, called AspireSR®, offers the ability to provide automatic stimulation in response to increased heart rate, in addition to its other stimulation timing. Since heart rate increases are seen prior to many seizures, the ability to provide stimulation at these times provides a way to respond directly at the time of a seizure. “AspireSR® expands the use of VNS Therapy to a responsive type of stimulation, which is the logical next step in devices for epilepsy,” commented Nathan Foundation, chair of the Epilepsy Foundation's Professional Advisory Board.

Our Mission

The mission of the Epilepsy Foundation is to lead the fight to overcome the challenges of living with epilepsy and to accelerate therapies to stop seizures, find cures, and save lives.

24/7 helpline